Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Hi, what are you looking for?
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Investment Creates Stand-Alone Company Poised for Growth in Physical-Security and Mission-Critical Operations Market
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
The Netanya-based mobile social gaming company was founded in 2012.
Sansa Security, which develops mobile and flash memory security solutions, will become ARM's Israel development center.
Exor and Axis have been locked in a three-way battle for control of PartnerRe.
J Sainsbury Plc (LON:SBRY) and Celesio AG (ETR:CLS1) owner of LloydsPharmacy Limited, have today announced the formation of a strategic partnership that will see...
French telecom billionaire broadens his media holdings
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Shanghai Jiuchuan will pay $130 million for 100% of SHL Telemedicine's shares.